ALOPECIA, ANDROGENETIC
Clinical trials for ALOPECIA, ANDROGENETIC explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA, ANDROGENETIC trials appear
Sign up with your email to follow new studies for ALOPECIA, ANDROGENETIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cream could help men regrow hair – phase 3 trial complete
Disease control CompletedThis Phase 3 study tested a topical solution called clascoterone in 703 men with mild to moderate male pattern baldness. Participants applied the solution or a placebo to their scalp twice daily for 6 months, and some continued for another 6 months. The goal was to see if clascot…
Matched conditions: ALOPECIA, ANDROGENETIC
Phase: PHASE3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New cream could help men regrow hair – phase 3 trial complete
Disease control CompletedThis Phase 3 trial tested a topical solution called clascoterone for male pattern hair loss. 762 men with mild to moderate balding applied the solution or a placebo twice daily for 6 months, followed by another 6 months for those who responded. The goal was to see if clascoterone…
Matched conditions: ALOPECIA, ANDROGENETIC
Phase: PHASE3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hair loss cream shows promise in early trial
Disease control CompletedThis phase 2 trial tested a new drug called TDM-105795 for male pattern baldness. 71 men with mild to moderate hair loss applied a solution to their scalp every day for 16 weeks. The study measured hair count and hair width to see if the treatment helped regrow hair.
Matched conditions: ALOPECIA, ANDROGENETIC
Phase: PHASE2 • Sponsor: Technoderma Medicines Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC